Article PDF first page preview

First page of Deep ulcers in Acute Severe Ulcerative Colitis at index endoscopy predict corticosteroid resistance

Background: Acute Severe Ulcerative Colitis (ASUC) is a life-threatening manifestation of UC that affects approximately 25% of patients. Initial management requires intravenous (IV) corticosteroids, yet about 30% of admitted patients do not respond. Objectives: This study aimed to identify endoscopic features at admission that could predict IV corticosteroid response in patients with ASUC at our center. Methods: Retrospective data were gathered from 62 patients hospitalized due to ASUC and were treated with IV corticosteroids. The Mayo Endoscopic Score (MES) and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) were collected from rectosigmoidoscopies performed at admission. Results: IV corticosteroids failed in 25.8% of patients with ASUC, necessitating the initiation of infliximab or cyclosporine. There were no significant associations between corticosteroid response and clinical or laboratory parameters, including serum albumin and C-reactive protein levels. The median UCEIS score was significantly higher in non-responders compared to responders (7, IQR 5-8 vs. 5, IQR 5-6; p=0.011) and it demonstrated good predictive performance for steroid non-response (AUC 0.717; p=0.005). Similarly, the MES showed a significant association with treatment outcomes (AUC 0.731; p=0.001), with a MES=2 displaying a 93.1% negative predictive value for IV steroid resistance. The type of ulcers (superficial vs. deep) on initial endoscopy emerged as the most robust predictor of corticosteroid response (AUC 0.771; p=0.001). Among patients with deep ulcers observed during the initial rectosigmoidoscopy, 66.7% were non-responders to corticosteroids, compared to only 13.3% of patients with superficial ulcers (p=0.002). Conclusions: Endoscopic features, particularly the presence of deep ulcers, are strong predictors of corticosteroid resistance in patients with ASUC. Upon admission, a rectosigmoidoscopy should be performed, and the presence of deep ulcers should help identify patients who may benefit from rescue therapies.

Journal Section:
Brief Report
This content is only available via PDF.
The Author(s). Published by S. Karger AG, Basel
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .
Attribution-NonCommercial